Assessment of immune function Management of patients with immunodeficiency disorders.

39
Assessment of immune function Management of patients with immunodeficiency disorders

Transcript of Assessment of immune function Management of patients with immunodeficiency disorders.

Page 1: Assessment of immune function Management of patients with immunodeficiency disorders.

Assessment of immune function

Management of patients with immunodeficiency disorders

Page 2: Assessment of immune function Management of patients with immunodeficiency disorders.

Disorders of Immune System

• Defenses against infection

• Immune system disorders– Autoimmune diseases– Immunodeficiency

Page 3: Assessment of immune function Management of patients with immunodeficiency disorders.

Defenses Against Infection

• Barriers (non-specific)– Skin– Mechanical removal (coughing, vomiting,

diarrhea, skin sloughing)– Normal flora– Antimicrobial secretions

• Inflammation (non-specific)

• Immunity (specific)

Page 4: Assessment of immune function Management of patients with immunodeficiency disorders.

Immune Response

• Natural vs. Acquired

• Active vs. Passive

• Primary vs. Secondary

• Humoral vs. Cell-Mediated

Page 5: Assessment of immune function Management of patients with immunodeficiency disorders.

Humoral Immunity

• B Lymphocytes (Plasma Cells)– Produced in bone marrow

–Make antibodies (immunoglobulins)

Page 6: Assessment of immune function Management of patients with immunodeficiency disorders.

Antibodies

• Protein molecules produced by B-cells

• Specific shapes allow binding to specific molecules (antigens)

• Allow body to respond defensively to presence of specific potential threats

Page 7: Assessment of immune function Management of patients with immunodeficiency disorders.

Antibody Types

• IgG

• IgM

• IgA

• IgD

• IgE

Page 8: Assessment of immune function Management of patients with immunodeficiency disorders.

IgG

• Most common antibody type

• Only antibody that crosses placenta

• Prime mediator of secondary immune response

• Principal defender against bacteria, viruses, and toxins

Page 9: Assessment of immune function Management of patients with immunodeficiency disorders.

IgM

• Macroglobulin

• Confined to bloodstream

• First antibody to appear in response to presence of antigen

• Agent of primary immune response

Page 10: Assessment of immune function Management of patients with immunodeficiency disorders.

IgA

• Secretory antibody

• Found in saliva, tears, respiratory secretions, GI tract secretions

• Frontline bacterial, viral defense

Page 11: Assessment of immune function Management of patients with immunodeficiency disorders.

IgD

• Role not fully understood

• Low serum levels

• High concentrations on B-cells

• May act as receptors that trigger production of other antibodies

Page 12: Assessment of immune function Management of patients with immunodeficiency disorders.

IgE

• Very low serum levels

• Primarily bound to mast cells in tissues

• Controls allergic response

• Prevents parasitic infections

Page 13: Assessment of immune function Management of patients with immunodeficiency disorders.

Antigen-antibody binding initiates reactions that:• Neutralize bacterial toxins

• Neutralize viruses

• Promote phagocytosis

• Activate components of inflammatory response

Page 14: Assessment of immune function Management of patients with immunodeficiency disorders.

Cell-Mediated Immunity

• T Lymphocytes–Originate in bone marrow

–Altered by passage through thymus

–Responsible for mediation of cellular immunity

Page 15: Assessment of immune function Management of patients with immunodeficiency disorders.

T Lymphocyte Types

• Helper cells (T4 cells)

• Cytotoxic cells (Killer T cells)

• Suppressor cells

• Memory cells

Page 16: Assessment of immune function Management of patients with immunodeficiency disorders.

Helper T-Cells

• Master “on-switch” of immune system

• Recognize antigens

• Secrete lymphokines that activate all other immune system cells

• Stimulate B-cells to begin antibody production

Page 17: Assessment of immune function Management of patients with immunodeficiency disorders.

Cytotoxic (Killer) T-Cells

• Respond to presence of antigens and lymphokines produced by T-4 cells

• Seek out, bind to, and destroy:– Cells infected by viruses– Some tumor cells– Cells of tissue transplants

• Can deliver lethal hits on multiple cells in sequence

Page 18: Assessment of immune function Management of patients with immunodeficiency disorders.

Suppressor T-Cells

• Produce lymphokines that inhibit proliferation of B and T cells

• Downregulate or dampen immune response

Page 19: Assessment of immune function Management of patients with immunodeficiency disorders.

Memory T-Cells

• Have previously encountered specific antigens

• Respond in enhanced fashion on subsequent exposures

• Induce secondary immune response

Page 20: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation• Occurs in vascularized tissue

• Nonspecific response to injury

• Response is same regardless of agent that initiates it

Page 21: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Physiology

• Triggered by cellular injury

• Injury activates mast cells

• Mast cells release chemical mediators:– Histamine– Heparin– Leukotrienes (SRS-A)– Eosinophil chemotactic factor

Page 22: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Pathology

• Mediators cause:– Vasodilation (redness, heat)– Vascular permeability (swelling)– White cell movement to and infiltration of

affected area (pus)– Nerve ending stimulation (pain)

“Dolor, Calor, Tumor, Rubor”

Page 23: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Purposes

• Confines injurious agents

• Increases blood cell, plasma movement to injured areas

• Enhances immune response

• Destroys injurious agents

• Promotes healing

Page 24: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Cellular Components

• Neutrophils– Phagocytic cells– Engulf foreign material/organisms– Arrive early– Short-lived

Page 25: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Cellular Components• Macrophages– Phagocytic cells– Engulf foreign material/organisms– Arrive later– Long-lived– Transfer antigens back to T4 cells– Help initiate immune response to specific

agents

Page 26: Assessment of immune function Management of patients with immunodeficiency disorders.

Inflammation: Cellular Components

• Eosinophils– Secrete caustic proteins– Dissolve surface membranes of parasites

Page 27: Assessment of immune function Management of patients with immunodeficiency disorders.

Disorders of Immunity

Page 28: Assessment of immune function Management of patients with immunodeficiency disorders.

Autoimmune Disease

• Clinical disorder produced by an immune response to a normal tissue component of a patient’s body

Page 29: Assessment of immune function Management of patients with immunodeficiency disorders.

Autoimmune Diseases

• Hyperthyroidism

• Primary myxedema

• Type I diabetes

• Addison’s disease

• Multiple sclerosis

• Myasthenia gravis

Page 30: Assessment of immune function Management of patients with immunodeficiency disorders.

Autoimmune Diseases

• Rheumatic fever

• Crohn’s disease

• Ulcerative colitis

• Rheumatoid arthritis

• Systemic lupus erythematosis

Page 31: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Primarily occurs in 20- to 40-year old females• Also in children and older adults• 90% of patients are female• Autoimmune reaction to host DNA• Mortality after diagnosis averages 5% per year

Page 32: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Signs/Symptoms– Facial rash/skin rash

triggered by sunlight exposure

– Oral/nasopharyngeal ulcers

– Fever

– Arthritis

Page 33: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Signs/Symptoms– Serositis (pleurisy, pericarditis)– Renal injury/failure– CNS involvement with

seizures/psychosis– Peripheral vasculitis/gangrene– Hemolytic anemia

Page 34: Assessment of immune function Management of patients with immunodeficiency disorders.

Systemic Lupus Erythematosis

• Chronic management– Anti-inflammatory drugs• Aspirin• Ibuprofen• Corticosteroids

–Avoidance of emotional stress, physical fatigue, excessive sun exposure

Page 35: Assessment of immune function Management of patients with immunodeficiency disorders.

Disorders of Immunity

Immunodeficiency Diseases

Page 36: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases

• Congenital

• Acquired

Page 37: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases: Congenital

• B cell deficiency– Agammaglobulinemia– Hypogammaglobulinemia

Page 38: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases: Congenital• T cell deficiency

• IgA deficiency

• Severe combined immune deficiency syndrome (B and T cell deficiency)

Page 39: Assessment of immune function Management of patients with immunodeficiency disorders.

Immunodeficiency Diseases: Acquired

• Nutritional deficiency

• Iatrogenic (drugs, radiation)

• Trauma (prolonged hypoperfusion)

• Stress

• Infection (AIDS)